Indeed, while DDX21 plays an oncogenic role in colorectal [14], gastric [15] and other cancers [16], downregulation of its expression correlates with dismal prognosis in breast cancer [17] and kidney renal papillary cell carcinoma [16]. This evidence concerns the gene DDX21 and cancer.